Provided by Tiger Trade Technology Pte. Ltd.

INVO BioScience, Inc.

0.8330
0.0000
Volume:- -
Turnover:105.54K
Market Cap:3.25M
PE:-0.32
High:0.8330
Open:0.8330
Low:0.8330
Close:0.8330
52wk High:3.50
52wk Low:0.5200
Shares:3.91M
Float Shares:3.88M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5637
EPS(LYR):-5.1308
ROE:-14358.64%
ROA:-26.57%
PB:-0.53
PE(LYR):-0.16

Loading ...

BRIEF-Invo Bioscience Confirms Corporate Name Change And New Trading Symbol

Reuters
·
Oct 21, 2024

INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection With Its Recent Merger With Naya Biosciences

THOMSON REUTERS
·
Oct 21, 2024

Naya Biosciences Inc - to Trade Under New Symbol 'Naya' From Oct 22

THOMSON REUTERS
·
Oct 21, 2024

INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences

GlobeNewswire
·
Oct 21, 2024

INVO Bioscience Completes Merger With NAYA Biosciences Acquisition

MT Newswires Live
·
Oct 14, 2024

Press Release: INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

Dow Jones
·
Oct 14, 2024

BRIEF-INVO - Entered Fourth Amendment To Previously Announced Agreement & Plan Of Merger By INVO Merger Sub And NAYA Biosciences

Reuters
·
Sep 19, 2024

INVO Bioscience Inc -Pursuant to Fourth Amendment, Agreed to Extend End Date of Merger to October 14

THOMSON REUTERS
·
Sep 19, 2024

INVO Bioscience- Entered Fourth Amendment to Previously Announced Agreement & Plan of Merger by INVO Merger Sub and Naya Biosciences

THOMSON REUTERS
·
Sep 19, 2024

INVO BioScience Q2 EPS $(0.62) Up From $(3.06) YoY; Revenue $1.826M Up From $315,902 YoY

Benzinga
·
Aug 14, 2024

Press Release: INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

Dow Jones
·
Aug 14, 2024

BRIEF-Invo Bioscience On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq

Reuters
·
Jun 21, 2024

INVO Bioscience: on June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request for Continued Listing on Nasdaq

THOMSON REUTERS
·
Jun 21, 2024

INVO Bioscience Inc :Invo Bioscience Inc Files For Mixed She

THOMSON REUTERS
·
May 22, 2024